Mobileye Appoints Moran Shemesh as New CFO, Replacing Anat Heller – C-Suite Transitions
Welcome to edition 58 of C-Suite Transitions, a weekly series on InsideArbitrage that tracks appointments and departures at publicly traded companies during the prior week. We highlight five appointments and departures each week by picking the largest companies from the full list of management changes.
Sudden Departures
- KWR: On September 5, 2023, President and Chief Accounting Officer David A. Will resigned from Quaker Chemical Company effective October 2, 2023.
- TPST: On September 2, 2023, President Tom Dubensky resigned from his role at Tempest Therapeutics and will transition to an advisor role on September 15, 2023.
- CRSP: On September 7, 2023, Co-Founder and President Rodger Novak resigned from CRISPR Therapeutics AG effective September 15, 2023.
Mobileye (MBLY) $35.48
Key Insights
- Anat Heller, the former CFO of Mobileye resigned abruptly citing undisclosed personal reasons. Acting CFO Moran Shemesh Rojansky has now been appointed as the permanent CFO.
- Intel Corp (INTC) sold 35 million shares of Class A common stock of Mobileye, equivalent to approximately $1.5 billion stake.
- Mobileye holds $1.1 billion in cash and cash equivalents and maintains a debt-free status.
Only plus or premium subscribers can access this post. Subscribe today.
